US Patent 7781446 Use of CCI-779 as an antineoplastic agent
Patent 7781446 was granted and assigned to Wyeth on August, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+88 characters)
Article
Patent abstract
This invention provides the use of CCI-779 in the treatment of neoplasms.
Edits on 18 Sep, 2023
Golden AI
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
Carolyn Mary Discafani-Marro0
Gary Dukart0
James J. Gibbons, Jr.0
Lisa Anne Speicher0
Philip Frost0
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07781446 Use of CCI-779 as an antineoplastic agent US Patent 7781446 Use of CCI-779 as an antineoplastic agent
Infobox
Patent Number
07781446
Patent Number
7781446
Edits on 3 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 5 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07781446 Use of CCI-779 as an antineoplastic agent
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07781446
Date of patent
August 24, 2010
Patent application number
11701109
Date Filed
February 1, 2007
Patent primary examiner
Find more entities like US Patent 7781446 Use of CCI-779 as an antineoplastic agent
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
